CryoLife, a developer of biomaterials and biosurgical devices such as BioGlue, has raised an additional $15 million through a line of credit.
CryoLife secured the funding commitment from Wells Fargo Foothill. The credit is available through 2008.
The company said the funds would be used for general corporate purposes.
CryoLife: www.cryolife.com
